Abstract
Purpose of review: To review recent findings regarding the control and treatment of campylobacteriosis. Recent findings: The application of improved diagnostics has led to an upward shift in the attributable burden of Campylobacter infections, in both the United States and Europe as well as in resource-poor settings. Increased focus has brought a fundamental feature of campylobacteriosis - the ability to cause relapsing disease back into focus, and expanding data on antimicrobial resistance has lead from a switch in first-line therapy for severe diarrhea from quinolones to azithromycin in most contexts, even as evidence of expanding macrolide resistance emerges. Summary: Campylobacter spp. infection is a common infection worldwide. Antibiotic-resistant Campylobacter spp. has become an emerging threat with the increase in industrial poultry production, as well as the broad use of antibiotics in both animals and humans.
Original language | English (US) |
---|---|
Pages (from-to) | 453-460 |
Number of pages | 8 |
Journal | Current opinion in infectious diseases |
Volume | 32 |
Issue number | 5 |
DOIs | |
State | Published - Oct 1 2019 |
Keywords
- Campylobacter spp.
- One Health
- antimicrobial resistance
- vaccines
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases